Kent Taylor Tinnitus Therapeutic Award
Forecasted
Kent Taylor Tinnitus Therapeutic Award funds therapeutic development and clinical validation to advance a promising treatment toward clinical use and relief for people living with tinnitus.
Funder: American Tinnitus Association
Due Dates (Anticipated): April 2027 (Application deadline)
Funding Amounts: Up to $1 million over 3 years
Summary: Supports development and clinical validation of a promising tinnitus therapeutic intervention to advance it toward clinical application and patient relief.
Key Information: A Letter of Intent is required.
Description
The American Tinnitus Association’s Kent Taylor Tinnitus Therapeutic Award supports the advancement of a promising therapeutic intervention toward clinical application and relief for people living with tinnitus. Established in honor of Kent Taylor’s legacy and Texas Roadhouse, the award focuses on accelerating the development and clinical validation of promising treatments.
The award addresses the continuing need for effective options for millions of people living with bothersome tinnitus. Despite advances in research, treatment options remain limited, leaving many people without meaningful relief. Its emphasis on translating therapeutic promise into clinical application reflects ATA’s mission to advance effective treatments and, ultimately, a cure.
